Skip to main content
SpringerLink
Log in

The Role of Insulin-Like Growth Factor Binding Proteins in Controlling the Expression of IGF Actions

  • Chapter
Molecular and Cellular Biology of Insulin-like Growth Factors and Their Receptors

Abstract

Although the insulin-like growth factors are secreted into blood and transported to peripheral tissues where they can act as traditional endocrine hormones, they are also synthesized and secreted by many types of cells and may exert their effects in the local microenvironment by autocrine or paracrine regulatory mechanisms. Specifically, IGF-I mRNA has been detected by in situ hybridization in connective tissue cells in several human tissues1. This mRNA appears to be translated and the peptide secreted since several types of cells in culture, such as fibroblasts, have been shown to secrete IGF-I2,3. Furthermore, blocking the binding of cell-secreted IGF-I to the type I IGF receptor will block mitogenic response in the fibroblasts that constitutively synthesize this peptide4. These data suggest that IGF-I is made by the connective tissue cell types within organs, and is secreted into interstitial fluids. Following secretion IGF-I not only binds to receptors on fibroblasts but it can bind also to receptors on cells of epithelial origin that contain receptors but do not contain IGF-I mRNA. Immunocytochemical localization studies have shown IGF-I to be present on the surfaces of many cell types that apparently do not synthesize and secrete this peptide5.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Han, V.KM.; D’Ercole, A.J.; Lund, P.K.: Cellular location of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236: 193–197 (1987).

    Article  PubMed  CAS  Google Scholar 

  2. Clemmons, D.R.; Elgin, R.G.; Han, V.KM.; Casella, S.J.; D’Ercole, A.J.; Van Wyk, J.J.: Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulin-like growth factor I. J.Clin.Invest. 77: 1548–1558 (1986).

    Article  PubMed  CAS  Google Scholar 

  3. Hill, D.J.; Crace, C.J.; Fowler, L.; Holder A.T.; Milner D.G.: Cultured fetal rat myoblasts release peptide growth factors which are immunologically and biologically similar to somatomedin. J Cell Physiol 117: 349–358 (1984).

    Article  Google Scholar 

  4. Clemmons, D.R.; Van Wyk, J.J.: Evidence for a functional role of endogenously produced somatomedin-like peptide in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. J Clin Invest 75: 1914–1918 (1985).

    Article  PubMed  CAS  Google Scholar 

  5. Han, V.K.M.; Hill, D.J.; Strain, A.J.; Towle, A.C.; Lauder, J.M.; Underwood, L.E.; D’Ercole, A.J.: Identification of somatomedin/insulin-like growth factor immunoreactive cells in the human fetus. Ped Res 22: 245–249 (1987).

    Article  CAS  Google Scholar 

  6. Nissley, S.P.; Rechler, M.M.: Insulin-like growth factors: biosynthesis, receptors and IGF-carrier proteins; in Li, C.H., ed. Hormonal Proteins and Peptides XII, pp. 127–203 (Academic Press, New York 1985).

    Google Scholar 

  7. Hintz, R.L.; Liu, F.: Demonstration of specific plasma protein binding sites for somatomedin. J. Clin. Endocrinol. Metab. 45: 988–995 (1977).

    Article  PubMed  CAS  Google Scholar 

  8. Moses, A.C.; Freinkel, A.J.; Knowles, B.B.; Aden, D.P.: Demonstration that a human hepatoma cell line produces a specific insulin-like growth factor carrier protein. J.Clin.Endocrinol.Metab. 56: 1003–1008 (1983).

    Article  PubMed  CAS  Google Scholar 

  9. Hill, D.J.; Clemmons, D.R.; Wilson, S.; Hall, V.K.M.; Strain, A.J.; Milner, D.G.: Immunological distribution of one form of insulin-like growth factor (IGF) binding protein and IGF peptides in human fetal tissues. J Mol Endo 3: 154–159 (1988).

    Google Scholar 

  10. Drop, S.LS.; Kortleve, D.J.; Guyda, H.J.: Isolation of a somatomedin binding protein from preterm human amniotic fluid: development of a radioimmunoassay. J.Clin.Endocrinol.Metab. 59: 899–905 (1984).

    Article  PubMed  CAS  Google Scholar 

  11. Copeland, K.C.; Underwood, L.E.; Van Wyk, J.J.: Induction of immunoreactive somatomedin-C in human serum by growth hormone dose response relationships and effect on Chromatograph profiles. J Clin Endocrinol Metab 50: 690–698 (1980).

    Article  PubMed  CAS  Google Scholar 

  12. Baxter, R.C.; Martin, J.L.: Radioimmunoassay of growth hormone dependent insulin-like growth factor binding protien in human plasma. J.Clin.Invest. 78: 1504–1512 (1986).

    Article  PubMed  CAS  Google Scholar 

  13. Baxter, R.C.: Characterization of the acid labile subunit of the growth hormone dependent insulin like growth factor binding protein complex. J.Clin.Endocrinol.Metab. 67: 265–272 (1988).

    Article  PubMed  CAS  Google Scholar 

  14. Wood, W.I.; Cathianes, G.; Henzel, W.J.; Winslow, G.A.; Spencer, S.A.; Hellmiss, R.; Martin, J.L.; Baxter, R.C.: Cloning and expression of the GH dependent insulin like growth factor binding protein. Mol.Endo. 2:1176–1185 (1988).

    Article  CAS  Google Scholar 

  15. Martin, J.L.; Baxter, R.C.: Insulin like growth factor binding protein from human plasma. Purification and characterization. J.Biol.Chem. 261: 8754–8760 (1988).

    Google Scholar 

  16. Wilkins, J.R.; D’Ercole, A.J.: Affinity labelled somatomedin-C insulin-like growth factor binding proteins: Evidence of growth hormone dependent subunit structures. J Clin Invest 75: 1350–1358 (1985).

    Article  PubMed  CAS  Google Scholar 

  17. Hossenlopp, P.; Seurin, D.; Segovia, B.; Portolan, G.; Binoux, M.: Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 2 forms released by human and rat liver in culture. Eur.J.Biochem. 170: 133–142 (1987).

    Article  PubMed  CAS  Google Scholar 

  18. Baxter, R.C.; Martin, J.L.; Wood, M.H.: Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. J.Clin.Endocrin.Metabol. 65: 423–431 (1987).

    Article  CAS  Google Scholar 

  19. Drop, L.S.; Kortleve, D.J.; Guyda, H.J.; Posner, B.I.: Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal, and adult sera. J.Clin.Endocrinol.Metab. 59:908–915 (1984).

    Article  PubMed  CAS  Google Scholar 

  20. Zapf, J.; Waldvogel, M.; Froesch, E.R.: Binding of nonsuppressible insulin-like activity to human serum: Evidence for a carrier protein. Arch.Biochem.Biophys. 168: 638–645 (1975).

    Article  PubMed  CAS  Google Scholar 

  21. White, R.M.; Nissley, S.P.; Moses, A.C.; Rechler, M.M.; Johnsonbarvh, R.E.: The growth hormone dependence of somatomedin binding protein in human sera. J Clin Endocrinol Metab 53: 49–57 (1981).

    Article  PubMed  CAS  Google Scholar 

  22. Koistinen, R.; Huhtala, M.L.; Stenman, U.H.; Seppala, M.: Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physicochemical and somatomedin-binding properties. Clin Chim Acta 164: 293–303 (1987).

    Article  PubMed  CAS  Google Scholar 

  23. Povoa, G.; Enberg, G.; Jornvall, H.; Hall, K.: Isolation and characterization of a somatomedin binding protein from mid term human amniotic fluid. Eur.J.Biochem. 144: 199–204 (1984).

    Article  PubMed  CAS  Google Scholar 

  24. Koistinen, R.; Kalkkinen, N.; Huhtala, M.L.; Seppala, M.; Bohn, H.; Rutanen, E.M.: Placental protein 12 is a decidual protein and has an identical N-terminal amino acid sequence with somatomedin binding protein in human amniotic fluid. Endocrinology 118: 1375–1184 (1986).

    Article  PubMed  CAS  Google Scholar 

  25. Brewer, M.T.; Stetler, G.L.; Squires, C.H.; Thompson, R.C.; Busby, W.H.; Clemmons, D.R.: Cloning, characterization and expression of a human insulin- like growth factor binding protein. Biochem.Biophys.Res.Comm. 152: 1289–1297 (1988).

    Article  PubMed  CAS  Google Scholar 

  26. Lee, Y.L.; Hintz, R.L.; James, D.M.; Lee, P.DK.; Shively, J.E.; Powell, D.R.: Insulin like growth factor IGF binding protein complementary deoxyribonucleic acid form human Hep G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of IGF-I and IGF-II receptors. Mol.Endo. 3: 404–411 (1988).

    Article  Google Scholar 

  27. Julkunen, M.; Koistinen, R.; Setala, K.A.; Seppala, M.; Janne, O.; Kontula, K.: Primary structure of human insulin-like growth factor binding protein/placental protein 12 and tissue specific expression of its mRNA. FEBS Lett 236: 295–352 (1988).

    Article  PubMed  CAS  Google Scholar 

  28. Rouslahti, E.; Pierschbacher, M.D.: Arg-Gly-Asp: A versatile recognition signal. Cell 44: 517–518 (1988).

    Article  Google Scholar 

  29. Shaw, G.; Kamen, R.P.: A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediating selective mRNA degradation. Cell 46: 659–667 (1986).

    Article  PubMed  CAS  Google Scholar 

  30. Rutanen, E.-M.; Koistinen, R.; Wahlstrom, T.; Bohn, H.; Ranta, T.; Seppala, M.: Synthesis of placental protein 12 by human decidua. Endocrinol. 116: 1304–1309 (1985).

    Article  CAS  Google Scholar 

  31. Rutanen, E.-M.; Koistinen, R.; Sjoberg, J.; Julkunen, M.; Wahlstrom, T.; Bohn, H.; Seppala, M.: Synthesis of placental protein 12 by human endometrium. Endocrinol. 118: 1067–1071 (1986).

    Article  CAS  Google Scholar 

  32. Thrailkill, K.; Clemmons, D.R.; Handwerger, S.: Control of Secretion of IGF 25 kDa binding protein by human decidual cells. Annual Meeting of the American Society of Clinical Investigation. Washington, D.C.,: (1989).(Abstract)

    Google Scholar 

  33. Hill, D.J.; Camacho-Hubner, C.; Rashid, P.; Strain, A.J.; Clemmons, D.R.: Insulin like growth factor binding protein secretion by human fibroblasts: Dependency on cell density and IGF peptides. Journal of Endocrinology (1989).(in press)

    Google Scholar 

  34. Camacho-Hubner, C.; McCusker, R.H.; Clemmons, D.R.: Insulin like growth factor binding protein secretion by human tumor cells is horraonally regulated. 70th Annual Meeting of the Endocrine Society (1988). Abstract #526.

    Google Scholar 

  35. McCusker, R.M.; Clemmons, D.R.: Insulin like growth factor binding protein secretion by muscle cells: Effect of cellular differentiation and proliferation. J.Cell Physiol. 137: 505–512 (1988).

    Article  PubMed  CAS  Google Scholar 

  36. McCusker, R.H.; Camacho-Hubner, C.; Clemmons, D.R.: Identification of the types of insulin like growth factor binding proteins that are secreted by muscle cells in vitro. J.Biol.Chem. in press: (1989).

    Google Scholar 

  37. Adams, S.O.; Kapadia, M.; Mills, B.; Daughaday, W.H.: Release of insulin-like growth factors and binding proteins into serum-free medium of cultured human fibroblasts. Endocrinol. 115: 520–526 (1984).

    Article  CAS  Google Scholar 

  38. Martin, J.L.; Baxter, R.C.: Insulin like growth factor binding proteins IGF-BP’s produced by human skin fibroblasts immunological relationship to other IGF-BP’s. J Clin Endocrinol Metab 123: 1907–1915 (1989).

    Google Scholar 

  39. Busby, W.H.; Snyder, D.K.; Clemmons, D.R.: Radioimmunoassay of a 26000 dalton plasma insulin like growth factor binding protein: Control by nutritional variables. J.Clin.Endocrinol.Metab. 67: 1231–1236 (1988).

    Article  Google Scholar 

  40. Baxter, R.C.; Colwell, C.T.: Diurnal rhythm of growth hormone dependent binding protein for insulin-like growth factors in human plasma. J.Clin.Endocrinol.Metab. 65: 432–440 (1987).

    Article  PubMed  CAS  Google Scholar 

  41. Sukkari, A.M.; Koistinen, V.A.; Rutanen, E.M.; Jarvinen, H.; Karonen, S.L.; Seppala, M.: Insulin regulates serum levels of low molecular weight insulin like growth factor binding protein. J.Clin.Endocrinol.Metab. 66: 266–273 (1988).

    Article  Google Scholar 

  42. Sukkari, A.M.; Koivisto, V.A.; Koistinen, R.; Seppala, M.; Yki-Jarvinen, H.: Dose response characteristics for suppression of low molecular weight plasma insulin like growth factor binding proteins by insulin. J Clin Endocrinol Metab 68: 135–140 (1989).

    Article  Google Scholar 

  43. Povoa, G.; Roovete, A.; Hall, K.: Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol. 107: 563–570 (1984).

    PubMed  CAS  Google Scholar 

  44. Iino, K.; Sjoberg, J.; Seppala, M.: Elevated circulating levels decidual protein placental protein 12 in preclampsia. Obst and Gyn 68: 58–60 (1986).

    CAS  Google Scholar 

  45. Iino, K.; Seppala, M.; Heinonen, P.K.; Scipponen, P.; Rutanen, E.M.: Elevated levels of somatomedin binding protein PP12 in patients with ovarian cancer. Cancer 58: 2294–3000 (1986).

    Article  PubMed  CAS  Google Scholar 

  46. Rutanen, E.M.; Wahlstrom, T.; Koistinen, R.; Scipponen, P.; Jalanko, H.: Plancental protein 12 in primary liver cancer and cirrhosis. Tumor Biology 5: 95–102 (1984).

    PubMed  CAS  Google Scholar 

  47. Elgin, R.G.; Busby, W.H.; Clemmons, D.R.: An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc.Natl.Acad.Sci. 84: 3254–3258 (1987).

    Article  PubMed  CAS  Google Scholar 

  48. Busby, W.H.; Klapper, D.G.; Clemmons, D.R.: Purification of a 31000 dalton insulin like growth factor binding protein from human amniotic fluid. J.Biol.Chenu 263: 14203–14210 (1988).

    CAS  Google Scholar 

  49. De Mellow, J.SM.; Baxter, R.C.: Growth hormone dependent insulinlike growth factor binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in skin fibroblasts. Biochem. Biophys. Res. Commun. 156: 199–204 (1988).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, CB #7170, University of North Carolina School of Medicine, Chapel Hill, NC, 27599-7170, USA

    David R. Clemmons

Authors
  1. David R. Clemmons
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Institutes of Health, Bethesda, Maryland, USA

    Derek LeRoith

  2. University of Florida, Gainesville, Florida, USA

    Mohan K. Raizada

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Clemmons, D.R. (1989). The Role of Insulin-Like Growth Factor Binding Proteins in Controlling the Expression of IGF Actions. In: LeRoith, D., Raizada, M.K. (eds) Molecular and Cellular Biology of Insulin-like Growth Factors and Their Receptors. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5685-1_32

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5685-1_32

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5687-5

  • Online ISBN: 978-1-4684-5685-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation